CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summary

Lucy McGeoch; Marinka Twilt; Leilani Famorca; Volodko Bakowsky; Lillian Barra; Susan Benseler; David A Cabral; Simon Carette; Gerald P Cox; Navjot Dhindsa; Christine Dipchand; Aurore Fifi-Mah; Michele Goulet; Nader Khalidi; Majed M Khraishi; Patrick Liang; Nataliya Milman; Christian A Pineau; Heather Reich; Nooshin Samadi; Kam Shojania; Regina Taylor-Gjevre; Tanveer E Towheed; Judith Trudeau; Michael Walsh; Elaine Yacyshyn; Christian Pagnoux; Canadian Vasculitis research network (CanVasc)

doi:10.1186/s40697-015-0078-1

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summary

Can J Kidney Health Dis. 2015 Nov 9:2:43. doi: 10.1186/s40697-015-0078-1. eCollection 2015.

Authors

Lucy McGeoch¹, Marinka Twilt², Leilani Famorca³, Volodko Bakowsky⁴, Lillian Barra⁵, Susan Benseler², David A Cabral⁶, Simon Carette⁷, Gerald P Cox⁸, Navjot Dhindsa⁹, Christine Dipchand¹⁰, Aurore Fifi-Mah¹¹, Michele Goulet¹², Nader Khalidi¹³, Majed M Khraishi¹⁴, Patrick Liang¹⁵, Nataliya Milman¹⁶, Christian A Pineau¹⁷, Heather Reich¹⁸, Nooshin Samadi¹⁹, Kam Shojania²⁰, Regina Taylor-Gjevre²¹, Tanveer E Towheed²², Judith Trudeau²³, Michael Walsh²⁴, Elaine Yacyshyn²⁵, Christian Pagnoux⁷; Canadian Vasculitis research network (CanVasc)

Affiliations

¹ Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario Canada ; Current address: Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK.
² Division of Pediatric Rheumatology, Alberta Children's Hospital, University of Calgary, Calgary, Alberta Canada.
³ Division of Rheumatology, McMaster University, Hamilton and Langs Community Centre, Cambridge, Canada.
⁴ Division of Rheumatology, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia Canada.
⁵ Division of Rheumatology, St. Joseph's Health Care, London, Ontario Canada.
⁶ Division of Pediatric Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, British Columbia Canada.
⁷ Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario Canada.
⁸ Division of Respirology, McMaster University, St. Joseph's Healthcare, Hamilton, Ontario Canada.
⁹ Division of Nephrology, Dalhousie University, Halifax, Nova Scotia.
¹⁰ Section of Rheumatology, University of Manitoba, Arthritis Centre, Winnipeg, Manitoba Canada.
¹¹ University of Calgary, Calgary, Alberta Canada.
¹² Division of Internal Medicine, Hôpital Du Sacré-Coeur, Montréal, Québec Canada.
¹³ Division of Rheumatology, McMaster University, Hamilton, Ontario Canada.
¹⁴ Division of Rheumatology, Memorial University of Newfoundland, Nexus Clinical Research, St. Johns, Newfoundland Canada.
¹⁵ Division of Rheumatology, Centre Hospitalier Universitaire de Sherbrooke, Québec, Canada.
¹⁶ Division of Rheumatology, the Ottawa Hospital/University of Ottawa, Ottawa, Ontario Canada.
¹⁷ Division of Rheumatology, Lupus and Vasculitis Clinic, McGill University, Montréal, Québec Canada.
¹⁸ Gabor Zellerman Chair in Nephrology Research of Toronto, Division of Nephrology, University Health Network, Toronto, Ontario Canada.
¹⁹ Division of Rheumatology and the Arthritis Program Research Group in Newmarket, Newmarket, Ontario Canada.
²⁰ Division of Rheumatology, Arthritis Research Canada, University of British Columbia, Vancouver, British Columbia Canada.
²¹ Division of Rheumatology, University of Saskatchewan, Saskatoon, Saskatchewan Canada.
²² Department of Medicine, Queen's University, Kingston, Ontario Canada.
²³ Division of Rheumatology, CHAU Hôtel-Dieu de Lévis, Université Laval, Québec, Canada.
²⁴ Department of Medicine and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario Canada.
²⁵ Division of Rheumatology, University of Alberta, Edmonton, Alberta.

Abstract

The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties, including rheumatology and nephrology and researchers with expertise in vasculitis. One of its aims was to develop recommendations for the diagnosis and management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides in Canada. This executive summary features the 19 recommendations and 17 statements addressing general AAV diagnosis and management, developed by CanVasc group based on a synthesis of existing international guidelines, other published supporting evidence and expert consensus considering the Canadian healthcare context.

Publication types

Review